Zachary K. Goldsmith, PhD et al. 2020. Anti-Platelet-Derived Growth Factor Receptor-Beta Therapy Does Not Trigger Retinal Endothelial Cell Toxicity. The Ophthalmology. (Dec. 2020), 5–10.